Skip to main content
Top
Published in: Drugs & Aging 12/2013

01-12-2013 | Letter to the Editor

Authors’ Reply to Toda: “The Effects of Fall-Risk-Increasing Drugs on Postural Control: A Literature Review”

Authors: Maartje H. de Groot, Jos P. C. M. van Campen, Marije A. Moek, Linda R. Tulner, Jos H. Beijnen, Claudine J. C. Lamoth

Published in: Drugs & Aging | Issue 12/2013

Login to get access

Excerpt

We thank Dr. Toda [1] for his interesting question. Dr. Toda asked, in response to our literature review [2], whether psychotropic drugs with longer half-lives are more likely to increase fall risk than psychotropic drugs with shorter half-lives. In our paper [2], we concluded that psychotropic fall-risk-increasing drugs (FRIDs) cause impairments in postural control, which is probably one of the mediating factors for the increased fall risk with which these FRIDs are associated. The effects of psychotropic FRIDs on postural control are more pronounced when people are of higher age, use psychotropics at higher daily dosages, for a longer period of time, and when the half-life of the drug is longer. By the latter, we mean that the effects on postural control of benzodiazepines with intermediate to long half-lives (>8 h) sustain for a longer period of time after taking the drug (the so-called hangover effect). …
Literature
2.
go back to reference De Groot MH, van Campen JPCM, Moek MA, Tulner LR, Beijnen JH, Lamoth CJC. The effects of fall-risk-increasing drugs on postural control: a literature review. Drugs Aging. 2013. doi:10.1007/s40266-013-0113-9. De Groot MH, van Campen JPCM, Moek MA, Tulner LR, Beijnen JH, Lamoth CJC. The effects of fall-risk-increasing drugs on postural control: a literature review. Drugs Aging. 2013. doi:10.​1007/​s40266-013-0113-9.
3.
go back to reference De Vries OJ, Peeters GMEE, Elders PJM, Sonnenberg C, Muller M, Deeg DJH, et al. The elimination half-life of benzodiazepines and fall risk: two prospective observational studies. Age Ageing. 2013. doi:10.1093/ageing/aft089. De Vries OJ, Peeters GMEE, Elders PJM, Sonnenberg C, Muller M, Deeg DJH, et al. The elimination half-life of benzodiazepines and fall risk: two prospective observational studies. Age Ageing. 2013. doi:10.​1093/​ageing/​aft089.
4.
go back to reference Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. psychotropic drugs. J Am Geriatr Soc. 1999;47:30–9.PubMed Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. psychotropic drugs. J Am Geriatr Soc. 1999;47:30–9.PubMed
Metadata
Title
Authors’ Reply to Toda: “The Effects of Fall-Risk-Increasing Drugs on Postural Control: A Literature Review”
Authors
Maartje H. de Groot
Jos P. C. M. van Campen
Marije A. Moek
Linda R. Tulner
Jos H. Beijnen
Claudine J. C. Lamoth
Publication date
01-12-2013
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 12/2013
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-013-0132-6

Other articles of this Issue 12/2013

Drugs & Aging 12/2013 Go to the issue

Acknowledgement to Referees

Acknowledgments

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.